Seer Inc (SEER)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $87.63M
Last updated: Nov 17, 2026 at 11:06 AM ET
Seer Inc (SEER) Earnings: Report Dates and Results
SEER is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, SEER reported EPS of -$0.25, above the -$0.26 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SEER has an expected report date of Feb 24, 2027.
SEER Earnings Call
The latest SEER earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 25 quarters below that had an estimate, SEER beat 15, missed 8 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $3.98M, down 3.4% from $4.12M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.25 | -$0.26 | -$0.27 - -$0.25 | +3.85% | Beat | N/A | 2 | 0 up, 2 down | Nov 10, 2026 | $3.98M |
| Jun 30, 2026 | -$0.31 | -$0.27 | -$0.29 - -$0.25 | -14.81% | Miss | N/A | 2 | 1 up, 0 down | Aug 11, 2026 | $3.10M |
| Mar 31, 2026 | -$0.30 | -$0.29 | -$0.31 - -$0.28 | -3.45% | Miss | N/A | 2 | 1 up, 0 down | May 13, 2026 | $2.79M |
| Dec 31, 2025 | -$0.29 | -$0.31 | N/A | +6.45% | Beat | N/A | 1 | 1 up, 0 down | Feb 26, 2026 | $4.20M |
| Sep 30, 2025 | -$0.32 | -$0.30 | -$0.30 - -$0.30 | -6.67% | Miss | N/A | 1 | 1 up, 0 down | Nov 6, 2025 | $4.12M |
| Jun 30, 2025 | -$0.33 | -$0.37 | -$0.39 - -$0.35 | +10.81% | Beat | N/A | 2 | 1 up, 1 down | Aug 6, 2025 | $4.05M |
| Mar 31, 2025 | -$0.34 | -$0.36 | -$0.39 - -$0.35 | +5.56% | Beat | N/A | 3 | 0 up, 1 down | May 13, 2025 | $4.21M |
| Dec 31, 2024 | -$0.37 | -$0.39 | -$0.41 - -$0.36 | +4.42% | Beat | N/A | 3 | 0 up, 3 down | Feb 27, 2025 | $4.00M |
| Sep 30, 2024 | -$0.35 | -$0.31 | -$0.35 - -$0.24 | -12.90% | Miss | N/A | 3 | 0 up, 0 down | Nov 6, 2024 | $4.03M |
| Jun 30, 2024 | -$0.35 | -$0.36 | -$0.37 - -$0.35 | +2.78% | Beat | N/A | 3 | 0 up, 0 down | Aug 8, 2024 | $3.07M |
| Mar 31, 2024 | -$0.32 | -$0.30 | -$0.34 - -$0.27 | -6.67% | Miss | N/A | 3 | 1 up, 0 down | May 8, 2024 | $3.07M |
| Dec 31, 2023 | -$0.28 | -$0.37 | -$0.41 - -$0.34 | +24.32% | Beat | N/A | 3 | 0 up, 0 down | Feb 29, 2024 | $4.44M |
| Sep 30, 2023 | -$0.33 | -$0.40 | -$0.44 - -$0.34 | +17.50% | Beat | N/A | 3 | 0 up, 0 down | Nov 7, 2023 | $4.16M |
| Jun 30, 2023 | -$0.37 | -$0.40 | -$0.43 - -$0.35 | +7.50% | Beat | N/A | 4 | 0 up, 0 down | Aug 8, 2023 | $4.01M |
| Mar 31, 2023 | -$0.38 | -$0.38 | -$0.42 - -$0.35 | 0.00% | In line | N/A | 4 | 0 up, 0 down | May 9, 2023 | $4.05M |
| Dec 31, 2022 | -$0.36 | -$0.43 | -$0.46 - -$0.39 | +16.28% | Beat | N/A | 4 | 0 up, 1 down | Mar 2, 2023 | $4.61M |
| Sep 30, 2022 | -$0.38 | -$0.39 | -$0.42 - -$0.36 | +2.56% | Beat | N/A | 4 | 0 up, 0 down | Nov 8, 2022 | $3.96M |
| Jun 30, 2022 | -$0.37 | -$0.39 | -$0.42 - -$0.34 | +5.13% | Beat | N/A | 4 | 0 up, 0 down | Aug 9, 2022 | $3.62M |
| Mar 31, 2022 | -$0.38 | -$0.39 | -$0.41 - -$0.38 | +2.56% | Beat | N/A | 3 | 0 up, 0 down | May 4, 2022 | $3.31M |
| Dec 31, 2021 | -$0.32 | -$0.32 | -$0.36 - -$0.29 | 0.00% | In line | N/A | 4 | N/A | Feb 28, 2022 | $3.07M |
| Sep 30, 2021 | -$0.30 | -$0.29 | -$0.29 - -$0.28 | -3.45% | Miss | N/A | 4 | N/A | Nov 9, 2021 | $2.15M |
| Jun 30, 2021 | -$0.27 | -$0.28 | -$0.28 - -$0.27 | +3.57% | Beat | N/A | 4 | N/A | Aug 12, 2021 | $1.33M |
| Mar 31, 2021 | -$0.27 | -$0.20 | -$0.25 - -$0.12 | -35.00% | Miss | N/A | 4 | N/A | May 10, 2021 | $62000 |
| Dec 31, 2020 | -$0.54 | -$0.48 | -$0.48 - -$0.48 | -12.50% | Miss | N/A | 1 | N/A | Mar 29, 2021 | $336000 |
| Sep 30, 2020 | -$0.12 | -$0.73 | N/A | +83.56% | Beat | N/A | N/A | N/A | Dec 4, 2020 | $72000 |
| Jun 30, 2020 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 25, 2020 | $71000 |
| Sep 30, 2019 | -$0.63 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2019 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.28, after -$1.39 the year before. It was -$1.35 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.28 | N/A |
| Dec 31, 2024 | -$1.39 | N/A |
| Dec 31, 2023 | -$1.36 | N/A |
| Dec 31, 2022 | -$1.49 | N/A |
| Dec 31, 2021 | -$1.16 | N/A |
| Dec 31, 2020 | -$1.35 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,500 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,463 | 6 | |
| 2026Q2 | Jun 30, 2026 | 4,511 | 6 | |
| 2026Q1 | Mar 31, 2026 | 5,208 | 6 | |
| 2025Q4 | Dec 31, 2025 | 5,543 | 5 | |
| 2025Q3 | Sep 30, 2025 | 4,690 | 5 | |
| 2025Q2 | Jun 30, 2025 | 5,028 | 6 | |
| 2025Q1 | Mar 31, 2025 | 4,257 | 5 | |
| 2024Q4 | Dec 31, 2024 | 6,432 | 7 |
2026Q3 Earnings Call
Opening remarks
Marissa Bych Gilmartin Group Representative Thank you. Earlier today, Seer released financial results for the quarter ended September 30, 2026. If you have not received this news release, or if you would like to be added to the company's distribution list, please send an email to investor@seer.bio. In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the Events and Presentations section of Seer's Investor Relations website. Participating today from Seer are Omid Farokhzad, Chief Executive Officer and Chair of the Board, and Charles Endweiss, Treasurer, Principal Financial Officer, and Principal Accounting Officer. Before we begin, I would like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section titled Forward-Looking Statements in the press release we issued today. For a more complete list and description, please see the Risk Factors section of the company's quarterly report on Form 10-Q for the quarter ended September 30, 2026, and in its other filings with the Securities and Exchange Commission. Except as required by law, Seer disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast today. With that, I would like to turn the call over to Omid.
Omid Farokhzad Chief Executive Officer and Chair of the Board Thank you, Marissa, and thank you all for joining us this afternoon. This quarter, our customers continued to demonstrate what Proteograph makes possible, from new biological discoveries in population-scale studies to emerging applications in AI. Established customers continue to purchase consumables, and new large biopharma customers adopted the Proteograph Product Suite for use in their own laboratories. These developments reinforce my conviction in the value of our technology and the business opportunity ahead for Seer. Our opportunity is to make deep, unbiased proteomics a routine part of research programs that require a more complete understanding of biology. Proteograph substantially expands what researchers can learn from mass spectrometry while allowing them to use existing LC-MS infrastructure. As this value becomes clearer across more applications, we have the opportunity to expand both our customer base and the use of the platform within each account. The business model connects directly to that use. Each additional sample processed with Proteograph requires assay consumables. A successful study can lead to a larger cohort, follow-up research, or adoption by another team within the same institution.
Frequently Asked Questions About SEER
When is SEER's next earnings date?
SEER's next earnings report is expected for Feb 24, 2027.
Did SEER beat earnings estimates last quarter?
Yes. SEER reported EPS of -$0.25 for the quarter ended Sep 30, 2026, above the -$0.26 estimate, a 3.85% surprise.
What EPS do analysts expect from SEER next quarter?
The consensus EPS estimate for SEER for the quarter ending Dec 31, 2026 is -$0.22 from 4 analysts, with estimates from -$0.22 to -$0.22.
How often does SEER beat earnings estimates?
SEER beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +0.77%.
SEER pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts